Reconnect after stroke
Closed
At IMPACT TRIALS we conduct research into new treatments and novel interventions for mental and physical health conditions
Our unit’s portfolio of work comprises of a breadth of research activites, our specialties include investigator lead clinical trials, development of service based interventions, creation of online and digital support programs, and the exploration of the biological underpinnings of prevelent mental and physical health conditions.
TRIALS is a dynamic team of researchers aiming to identify new treatments for a range of disorders. Innovation and cross-collaboration are the cornerstones of our research program.
About our work
IMPACT TRIALS works with collaborators both nationally and internationally. There have been a number of completed trials with agents including; N-acetyl cysteine, minocycline, mitochondrial enhancers, asprin, and rosuvastatin. Data from these trials provides rich sources to explore not only primary efficacy but also underlying factors related to treatment response.
TRIALS ultimately aims both to provide interventions that can be rolled out into clinical practice and to identify factors that will enhance personalised medicine in psychiatry
Studies
See below our upcoming, current and past studies at IMPACT TRIALS.
TRI-ME Trial: A new treatment trial for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Open
The Silexan in the Treatment Of Posttraumatic stress disorder (STOP) Trial
Open
WellCom Study: Recruitment of healthy participants to investigate blood markers relevant to psychiatric disorders.
Closed
Strive to Thrive after stroke
Closed
Tina Trial
Closed
Caring about return to work after a stroke
Closed
Returning to work after stroke in rural communities
Closed
BipolarWISE: A new program about living well with bipolar disorder
Closed
BipolarASSIST: A new program for family and friends of people with bipolar disorder
Closed
RESET (Resuming Employment after Stroke- Enhancement through Telecoordination) Advisory Network
Closed
CADET-UD Trial: New treatment trial for major depressive disorder
Open